D. E. Shaw & Co., Inc. Seagen Inc. Put Options Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 14, 2022	SELL	$142.57 - $190.86 $1.43 Million - $1.91 Million	-10,000 Reduced 30.3%	23,000 $3.56 Million
Q1 2021 May 17, 2021	SELL	$137.51 - $190.8 $1.46 Million - $2.02 Million	-10,600 Reduced 24.31%	33,000 $4.58 Million
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $7.18 Million - $9.24 Million	43,600 New	43,600 $7.64 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.